New medical product development Concept to product
How to attract investors
-and why they may be difficult to convince
Medtech Event for Start-ups and Investors
Why do many Medtech startups struggle to attract investors, and what makes an investor walk away from a promising medtech case?
This after-hours event will focus on investments in medtech startups and the considerations made on both sides of the table before an investment.
We will explore what makes a match and what can be a thorn in the eye of either party.
Join us for an after-hours event with great insights into the dynamics of the investor/startup dating phase, as both sides of the table will be represented and give their views on things.
Thursday, March 20th from 4.30 pm to 7.00 pm

Event Details
Speakers:
1. Kristine Kuni Buccoliero, CEO & Founder of NeoCare Nordic, creating a product for neonatal care, Investee of multiple rounds from a variation of experienced and new Medtech investors
2. Finn Ketler, Former VP of Woundcare, Coloplast, 15 years in the start-up environment, one listing on First North, Stockholm, Managing Partner of Coopmed that actively aids MedTech startups entering the European market. Investor in NeoCare Nordic among other Medtech companies
3. TBA
Program:
16:00-16:30 – Arrival + Welcome Drink
16:30-18:15 – Speakers + Q&A Panel on theme
18:15-19:00 – Networking + Drinks & perhaps a chance to discuss
Location:
Vesterbrogade 26, Republikken, 1620 Copenhagen
Paid Parking – Saga P-hus, Vesterbrogade 23
The event is open for people with an interest in Medtech.
Join us to discuss what medical device startups can do to improve their attractiveness and how investors can improve their assessment process of medtech startup.

Theme Background
When only scratching the surface, investments in medtech look better than ever. The industry has seen the second greatest increase in VC funding post-covid* -reaching an all time high of €30 Billion invested in a year. However, a still smaller share is going to medtech startups**, while an ever growing number of these startups compete for it.
The great question is: Why isn’t more of the investments going to medtech startups?, when they are renowned for:
- Addressing a need, the healthcare sector calls for new devices to handle the aging population, offer new treatments, and focus on limited staff.
- Market potential, medical devices often have high profit margins and a growing market.
- Scalability, products can often be adopted on multiple markets with small adjustments + a product is often part of a portfolio i.e. accessories.
This is at least how medical device companies pitch it.
The reasoning may be different through the eyes of investors, as medtech is also known for:
- Ambiguity & uncertainty, challenging payment structures i.e. reimbursement codes, troublesome regulatory pathways, and lack of clarity on who the payer is.
- Slow adoption, the healthcare sector can be slow at adopting new medical devices, delaying sales and profits.
- Long time to exit, the development of a medtech device often stretches over 5-8 years — that is a long horizon for many investors.
The above points call for a strategic funding approach from medtech startups and for educating investors to understand the value and difficulties of investing in this space.
Thus, the event will take offset in:
- What can medtech startups do to attract investors?
- What should investors look for in medtech startups?
Sources:
*+63 %, only surpassed by pharma/biotech with +66 %
** Decline from 29 % to 23 % in five years
New strategies for Medtech Startups. Attracting investment from across the innovation ecosystem, Deloitte, Advamed.
Facts & Figures 2024, Medtech Europe
Sign up for the event
Free admission & drink. Limited Capacity.
Surviving the
New medical product development Concept to product
Neonatal Device│Incubator
Innovative neonatal care device designed and developed in collaboration...
How to find Create Medtech
We are on Vesterbrogade 35A,
1620 København V.
Drop-in, book a meeting or give us a call.